Breast Cancer Research and Treatment

, Volume 167, Issue 3, pp 817–818 | Cite as

Hormone receptor-positive invasive lobular and ductal carcinoma of the breast have comparable hormone receptor expression levels both if detected by screening and clinically

Letter to the Editor



This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.


  1. 1.
    Truin W, Roumen RMH, Siesling S, van de Vijver KK, Tjan-Heijnen VCG, Voogd AC (2017) Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors. Breast Cancer Res Treat 164:133–138. doi: 10.1007/s10549-017-4220-x CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Anderson WF, Chu KC, Chang S, Sherman ME (2004) Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomark Prev 13:1128–1135Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Romagna Cancer Registry, Romagna Cancer Institute (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, IRCCS)ForlìItaly
  2. 2.Romagna Local Health UnitForlìItaly

Personalised recommendations